Today's video focuses on Apple (NASDAQ: AAPL), how the events surrounding the company are impacting investor sentiments, and finally, my thought process on determining whether this is something I should be worried about as a long-term investor. Check out the short video to learn
As the market has dropped, more and more deals are emerging for investors. Price-to-earnings multiples are coming down, cash levels have become more important, and even companies with wide moats are cheaper than they've been in years. Travis Hoium, Jason Hall, and Matt Frankel di
Volkswagen is in talks with Taiwan's Foxconn about a partnership to build vehicles for the Scout brand, German autos publication Automobilwoche reported on Tuesday, citing Volkswagen company sources.
(RTTNews) - Elon Musk, who recently took Twitter Inc. private in a $44-billion deal, accused Apple Inc. of threatening to block the social media platform from its app store without giving the reason.
U.S. stock index futures edged higher on Tuesday, with Tesla leading gains among beaten-down growth stocks amid hopes that the recent protests in China could lead to a quicker easing of strict COVID-19 curbs in the country.
Launched on 12/01/2016, the iShares ESG Aware MSCI USA ETF (ESGU) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Growth category of the market.
If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the WisdomTree U.S. Total Dividend ETF (DTD), a passively managed exchange traded fund launched on 06/16/2006.
Taiwan's economy is likely to grow more slowly than previously forecast this year and next, the statistics office said on Tuesday, as it also cut its exports outlook due to global inflation, rate rises and China's zero-COVID policy.
Asian shares rallied on Tuesday as Beijing's latest move to support developers boosted the property sector and rumours swirled that recent public unrest might prompt an earlier loosening in COVID-19 restrictions.
HONG KONG (Reuters Breakingviews) - Wealthy democracies want to cut their reliance on China. The People's Republic too has moved to become more self-sufficient. Tariffs, sanctions and suspicion have redirected flows of human and financial capita
When officials from his Chinese village approached Hou last month, urging him to work at the world's largest iPhone factory for at least twice the usual pay, he knew it was risky.
Asian shares edged higher on Tuesday as Beijing's latest move to support developers boosted the property sector, though it was still not clear what new damage public unrest over China's zero-COVID policy might do to the economy.
After a decade of making up to A$200,000 a year (about US$135,000) on oil and gas rigs as a fitter and subsea equipment specialist in Western Australia, Adam Naylor had had enough.
Rare protests rippling across China over Beijing's zero-COVID-19 policy may have unleashed a fresh wave of political uncertainty but could also hasten the reopening of the world's number two economy, foreign investors said on Monday.
With another month left for the tumultuous year of 2022 to end, it's a good time to prepare to make the most out of 2023 with Wall Street’s highest-rated stocks. Recently, Merck (
NYSE:MRK
), Eli Lilly (
NYSE:LLY
), Apple (
NASDAQ:AAPL
), and Salesforce (
NASDAQ:CRM
) have been rated favorably by Wall Street analysts.
Merck (MRK)
Pharmaceutical giant Merck is best known for its medications for life-threatening diseases. Its cancer drug, Keytruda, and its HPV vaccine Gardasil are the best-sellers that form the backbone of Merck’s product revenues.
Early this month, Guggenheim analyst
Seamus Fernandez maintained a Buy on MRK stock and raised his guidance on the sales of Keytruda, Gardasil, and the pulmonary arterial hypertension medication Sotatercept. This also prompted the analyst to increase his price target on the stock from $104 to $111.
To build its long-term portfolio, Merck is also tapping external sources. To that end, the company has made several strategic acquisitions which have been fruitful growth catalysts. The most recent acquisition was made last week when the company announced that it will acquire Imago BioSciences (
NASDAQ:IMGO
) for $1.35 billion.
What is the Price Target for MRK Stock?
MRK stock has a Strong Buy consensus rating on Wall Street. However, the average price target of $110.40 indicates 1.8% upside potential.
Eli Lilly (LLY)
Another pharmaceutical company that's popular on Wall Street is Eli Lilly. LLY's solid portfolio of drugs is widely used to treat diabetes, autoimmune diseases, and cancer. Demand for its medications is driving its revenue growth.
Eli Lilly consistently returns cash to shareholders through share repurchases and
dividends. The return of cash to shareholders through dividends and share buybacks was around $4.35 billion in 2021.
Not only that, but Lilly’s cost-reduction efforts are also bearing positive returns. In the past six years, the company has managed to achieve around 1,000 basis points worth of growth in its operating margin, which is impressive.
What is the Price Target for LLY Stock?
Earlier this month, Truist analyst
Robyn Karnauskas maintained a Buy rating on LLY stock and also raised her price target to $421 from $400. The failure of Roche’s (
OTC:RHHBY
) Alzheimer's drug trial led the analyst to estimate a 5% increase in the penetration rate of Lilly’s competing drug, donanemab.
Wall Street is optimistic about the stock, too, with a Strong Buy consensus rating based on 12 Buys and two Holds. The current price is forecast to reach $383.69, implying 4.9% upside potential.
Salesforce (CRM)
Now coming to technology, Salesforce, a leading provider of on-demand Customer Relationship Management software, is one of the biggest beneficiaries of the rapid digital transformation across the globe. Impressively, the company is targeting revenue of $50 billion by the Fiscal Year 2026. If it happens, Salesforce will be the fastest enterprise software company to achieve that milestone. On a trailing-12-month basis, the company generated
over $29 billion in revenue.
Additionally, Salesforce boasts a strong balance sheet with
cash of about $13.5 billion as of July 31, 2022. This makes it easier for the company to pursue growth initiatives and enhance shareholders’ value without the help of more debt. At the same time, Salesforce’s total-debt-to-total-capital ratio was 8.5%. This makes the company an attractive stock to investors who are looking for relatively safe bets.
Ahead of its Q3 results on November 30, Wedbush analyst
Daniel Ives reiterated an Outperform rating on Salesforce, with a price target of $215. The analyst expects Industry Cloud deal activity to have been high and Tableau and MuleSoft to have been better than expected.
What is the Price Target for CRM Stock?
Wall Street analysts think that CRM stock has the potential to increase by 38.8% over the next 12 months, reaching $213.31. Analysts have a Strong Buy consensus rating on CRM based on 24 Buys against seven Holds.
Apple (AAPL)
Apple is in a difficult situation currently, with a
significantly lower-than-expected iPhone Pro production in sight. However, strong fundamentals and its massive size make it one of the most popular stocks among investors.
Even hedge funds are bullish about the stock, with more than
675,000 shares added to hedge fund portfolios in Q3. Interestingly enough, about 42% of the portfolio of
Warren Buffet’s Berkshire Hathaway is made up of Apple stock.
However, even with Apple shares
down 20% year-to-date, it’s still not inexpensive, with a forward P/E of 23.7x. Nonetheless, Wedbush analyst Daniel Ives reiterated a Buy rating and $200 price target for Apple. “Our bullish thesis on Apple is demand-driven, which is very firm, although these brutal supply shortages in the near-term remain a clear overhang for the stock to navigate,” assured the analyst.
What is the Price Target for AAPL Stock?
Apple is a Wall Street darling, with a Strong Buy consensus rating based on 24 Buys and four Holds. The average AAPL price target stands at $180.48, which indicates 25.1% upside potential.
Ending Thoughts
One cannot deny the challenges that await companies this year and next. Nonetheless, it is the long-term view that matters, and Wall Street never fails to show us that.
Disclosure
Last week's mostly upbeat sentiment was forgotten on Monday as investors anxiously eyed the pushback the Chinese government is receiving for its prolonged Covid-19 restrictions. This unrest reverberated through global markets, denting tech amid reports that demonstrations
U.S. stocks ended sharply lower on Monday after protests in major Chinese cities against strict COVID-19 policies sparked concerns about economic growth, while Apple Inc slid on worries about a hit to iPhone production.
Technology stocks were ending near this intra-day lows on Monday, with the SPDR Technology Select Sector ETF (XLK) sinking 2.3% and the Philadelphia Semiconductor Index sliding 2.8% this afternoon.